Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib

被引:231
作者
Emsley, J
Cruz, M
Handin, R
Liddington, R [1 ]
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
[2] Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.273.17.10396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
von Willebrand Factor (vWF) is a multimeric protein that mediates platelet adhesion to exposed subendothelium at sites of vascular injury under conditions of high flow/shear. The Al domain of vWF (vWF-A1) forms the principal binding site for platelet glycoprotein Ib (GpIb), an interaction that is tightly regulated. We report here the crystal structure of the vWF-A1 domain at 2.3-Angstrom resolution. As expected, the overall fold is similar to that of the vWF-A3 and integrin I domains. However, the structure also contains N- and C-terminal arms that wrap across the lower surface of the domain. Unlike the integrin I domains, vWF-A1 does not contain a metal ion-dependent adhesion site motif. Analysis of the available mutagenesis data suggests that the activator botrocetin binds to the right-hand face of the domain containing helices alpha 5 and alpha 6. Possible binding sites for GpIb are the front and upper surfaces of the domain. Natural mutations that lead to constitutive GpIb binding (von Willebrand type IIb disease) cluster in a different site, at the interface between the lower surface and the terminal arms, suggesting that they disrupt a regulatory region rather than forming part of the primary GpIb binding site. A possible pathway for propagating structural changes from the regulatory region to the ligand-binding surface is discussed.
引用
收藏
页码:10396 / 10401
页数:6
相关论文
共 34 条
  • [21] RASTER3D VERSION-2.0 - A PROGRAM FOR PHOTOREALISTIC MOLECULAR GRAPHICS
    MERRITT, EA
    MURPHY, MEP
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 869 - 873
  • [22] OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P59
  • [23] CRYSTAL-STRUCTURE OF THE I-DOMAIN FROM THE CD11A/CD18 (LFA-1, ALPHA(L)BETA-2) INTEGRIN
    QU, AD
    LEAHY, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) : 10277 - 10281
  • [24] VONWILLEBRAND DISEASE TYPE-B - A MISSENSE MUTATION SELECTIVELY ABOLISHES RISTOCETIN-INDUCED VONWILLEBRAND-FACTOR BINDING TO PLATELET GLYCOPROTEIN-IB
    RABINOWITZ, I
    TULEY, EA
    MANCUSO, DJ
    RANDI, AM
    FIRKIN, BG
    HOWARD, MA
    SADLER, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) : 9846 - 9849
  • [25] Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor
    Rieu, P
    Sugimori, T
    Griffith, DL
    Arnaout, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) : 15858 - 15861
  • [26] von Willebrand factor
    Ruggeri, ZM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) : 559 - 564
  • [27] SADLER JE, 1995, THROMB HAEMOSTASIS, V74, P161
  • [28] SCOTT JP, 1991, J BIOL CHEM, V266, P8149
  • [29] Shear-dependent changes in the three-dimensional structure of human von Willebrand factor
    Siedlecki, CA
    Lestini, BJ
    KottkeMarchant, K
    Eppell, SJ
    Wilson, DL
    Marchant, RE
    [J]. BLOOD, 1996, 88 (08) : 2939 - 2950
  • [30] Siguret V, 1996, THROMB HAEMOSTASIS, V76, P453